tiprankstipranks
ContraFect (CFRXQ)
OTHER OTC:CFRXQ
US Market

ContraFect (CFRXQ) Technical Analysis

376 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
ContraFect’s (CFRXQ) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting ContraFect is a Buy.
ContraFect’s (CFRXQ) 20-Day exponential moving average is 0.02, while ContraFect’s (CFRXQ) share price is <$0.1, making it a Buy.
ContraFect’s (CFRXQ) 50-Day exponential moving average is 0.02, while ContraFect’s (CFRXQ) share price is <$0.1, making it a Sell.

ContraFect (CFRXQ) Pivot Points

Jul 17, 2024, 04:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ContraFect (CFRXQ) Moving Averages

Jul 17, 2024, 04:45 PM
Period
Simple
Exponential
MA5
0.02Sell
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Buy
0.02Buy
MA50
0.02Buy
0.02Sell
MA100
0.02Sell
0.05Sell
MA200
0.09Sell
0.19Sell
ContraFect’s (CFRXQ) 10-Day exponential moving average is 0.02, while ContraFect’s (CFRXQ) share price is <$0.1, making it a Sell.
ContraFect’s (CFRXQ) 100-Day exponential moving average is 0.05, while ContraFect’s (CFRXQ) share price is <$0.1, making it a Sell.
ContraFect’s (CFRXQ) stock price is <$0.1 and ContraFect’s (CFRXQ) 50-day simple moving average is 0.02, creating a Buy signal.
ContraFect’s (CFRXQ) stock price is <$0.1 and ContraFect’s (CFRXQ) 100-day simple moving average is 0.02, creating a Sell signal.
ContraFect’s (CFRXQ) stock price is <$0.1 and ContraFect’s (CFRXQ) 200-day simple moving average is 0.09, creating a Sell signal.

ContraFect (CFRXQ) Technical Indicators

Jul 17, 2024, 04:45 PM
Name
Value
Implied Action
RSI (14)
50.43
Neutral
STOCH (9,6)
33.33
Neutral
STOCHRSI (14)
33.33
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
62.17
Sell
Williams %R
-66.67
Buy
CCI (14)
-31.88
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
59.09
Neutral
ROC
0.00
-
ContraFect’s (CFRXQ) Relative Strength Index (RSI) is 50.43, creating a Neutral signal.
ContraFect’s (CFRXQ) Trend Strength Indicator (ADX) is 62.17, creating a Sell signal.
ContraFect’s (CFRXQ) Commodity Channel Index (CCI) is -31.88, creating a Neutral signal.

FAQ

Is CFRXQ a Buy, Hold, or Sell?
Based on CFRXQ’s technical indicators, CFRXQ is a Sell.
    What is CFRXQ’s RSI (14)?
    CFRXQ’s RSI (14) is 50.43, which suggests CFRXQ is a Neutral.
      What is CFRXQ’s MACD?
      CFRXQ’s MACD is <0.01, which suggests CFRXQ is a Buy.
        What is CFRXQ’s 5-day moving average?
        CFRXQ’s 5-day moving average is 0.02, which suggests CFRXQ is a Sell.
          What is CFRXQ’s 20-day moving average?
          CFRXQ 20-day moving average is 0.02, which suggests CFRXQ is a Buy.
            What is CFRXQ’s 50-day moving average?
            CFRXQ’s 50-day moving average is 0.02, which suggests CFRXQ is a Buy.
              What is CFRXQ’s 200-day moving average?
              CFRXQ’s 200-day moving average is 0.09, which suggests CFRXQ is a Sell.
                What is CFRXQ’s Williams % R (14)?
                CFRXQ’s Williams % R (14) is -66.67, which suggests CFRXQ is a Buy.
                  What is CFRXQ’s CCI (14)?
                  CFRXQ’s CCI (14) is -31.88, which suggests CFRXQ is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis